Cara Therapeutics Inc. sell StockNews.com
Start price
17.02.24
/
50%
€0.54
Target price
17.02.25
-
Performance (%)
-58.85%
Price
04.10.24
€0.25
Summary
This prediction is currently active. The SELL prediction by StockNews_com for Cara Therapeutics Inc. is performing very well with a performance of -58.85%. This prediction currently runs until 17.02.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cara Therapeutics Inc. | -0.960% | -0.960% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CARA provided by MarketBeat
Stopped prediction by StockNews_com for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.31
02.09.24
02.09.24
-
02.09.25
02.09.25
-18.75%
04.10.24
04.10.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.27
25.08.24
25.08.24
-
25.08.25
25.08.25
-17.98%
04.10.24
04.10.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.28
08.07.24
08.07.24
-
08.07.25
08.07.25
-12.94%
04.10.24
04.10.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.30
22.06.24
22.06.24
-
22.06.25
22.06.25
-17.08%
04.10.24
04.10.24